MENU

Clinical Trials
& Clinical Data

2024

Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis

LEARN MORE
2024

Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)

LEARN MORE
2024

Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial

LEARN MORE
2024

Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatmen

LEARN MORE
2023

Safety and Clinical Effects of a Muse Cell-Based Product in Patients With Amyotrophic Lateral Sclerosis: Results of a Phase 2 Clinical Trial

LEARN MORE
2023

Randomized placebo-controlled trial of CL2020, an allogenic muse cell-based product, in subacute ischemic stroke

LEARN MORE

SELECTED PUBLICATIONS

2025

Macrophage- and pluripotent-like reparative Muse cells are unique endogenous stem cells distinct from other somatic stem cells

LEARN MORE
2010

Unique multipotent cells in adult human mesenchymal cell populations

LEARN MORE
2025

Nose-to-brain delivery of human muse cells enhances structural and functional recovery in the murine ischemic stroke model

LEARN MORE
2024

Human post-implantation blastocyst-like characteristics of Muse cells isolated from human umbilical cord

LEARN MORE
2024

Human Muse cells isolated from preterm- and term-umbilical cord delivered therapeutic effects in rat bleomycin-induced lung injury model without immunosuppressant

LEARN MORE
2024

Intravenously engrafted human multilineage-differentiating stress-enduring (Muse) cells rescue erectile function after rat cavernous nerve injury

LEARN MORE

NEWS

2024

Muse Cells: A New Stem Cell Treatment

LEARN MORE